Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares") (TBPH)
CUSIP: G8807B106
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares")
- Total 13F shares
- 53,537,579
- Total 13F value
- $1,092,709,410
- Share change
- +223,593
- Put/Call ratio
- 81%
- SEC-reported price per share
- $20.41
- Number of holders
- 104
- Value change
- +$7,301,237
- Number of buys
- 40
- Number of sells
- 50
- Shares outstanding
- 52,046,621
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
104
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Shares, $0.00001 Par Value (the "Ordinary Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 18%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 18%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
18%
BAUPOST GROUP LLC/MA
17%
ORBIMED ADVISORS LLC
12%
WELLINGTON MANAGEMENT GROUP LLP
11%
VANGUARD GROUP INC
8.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
18%
|
$169,557,000
9,541,794 shares
|
— | 31 Dec 2020 |
| BAUPOST GROUP LLC/MA |
13F
Company
|
17%
|
$155,224,000
8,735,168 shares
|
— | 31 Dec 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
12%
|
$110,514,000
6,219,110 shares
|
— | 31 Dec 2020 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
11%
|
$97,154,000
5,467,300 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
8.9%
|
$82,708,000
4,654,309 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
8.6%
|
$79,810,000
4,491,195 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
104
Shares
53,537,579
Rows available
104
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q1 2021 Across Filers
Q1 2021 holders
104
Q1 2021 holders
104
Holder diff
0
| Investor | Q1 2021 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q1 2021 value | Value change | Value Chg % |
|---|